Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Omeros Corporation today announced that OMS has received orphan drug designation from the US Food and Drug Administration FDA for the treatment of paroxysmal nocturnal hemoglobinuria PNH OMS targets mannanbinding lectinassociated serine protease MASP...
Dr Reddys Laboratories Ltd today announced that it has entered into a licensing agreement with Princeton New Jersey based Slayback Pharma LLC Slayback to acquire rights in Slaybacks Brimonidine Tartrate Ophthalmic Solution the private label equivale...
Astria Therapeutics Inc a biopharmaceutical company developing STAR for hereditary angioedema and focused on lifechanging therapies for rare and niche allergic and immunological diseases today announced the US Food and Drug Administration FDA clearan...
Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced a collaboration with the Kenya Medical Research Institute KEMRI to plan seek regulatory approval for and conduct a Phase clinical study in Kenya to develop...
Sunshine Biopharma Inc a pharmaceutical company focused on the research development and commercialization of oncology and antiviral drugs today announced that it has agreed to provide additional resources to the University of Arizona R Ken Coit Colle...
Marinus Pharmaceuticals Inc a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders today announced the US commercial launch of ZTALMY ganaxolone oral suspension CV for the treatment of seizures ass...
Growing occurrence of genetic disorders and advances in healthcare technologies will fuel global gene editing market share Many developed and developing countries are witnessing a disturbing rise in rare disease cases According to the Cystic Fibrosis...
Biogen Inc announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for tofersen an investigational drug for superoxide dismutase SOD amyotrophic lateral sclerosis ALS The application has been granted priority r...
Sun Pharmaceutical Industries Limited and Cassiopea a subsidiary of Cosmo Pharmaceuticals NV today announced the signing of addendums to the License and Supply Agreements for WINLEVI clascoterone cream expanding the territory to include Japan Austra...
SomaLogic a leader in AI datadriven proteomics technology today announced it entered into an agreement to acquire Palamedrix Inc an innovator in DNA nanotechnology Palamedrix provides deep scientific and engineering expertise miniaturization technolo...
